Bohner, Marc

Richards, Geoff

Wandrey, Christine

RERO DOC Digital Library

EDITORIALThe 22nd European Conference on Biomaterials:retrospective view, facts and figuresChristine Wandrey • Marc Bohner •Geoff RichardsPublished online: 12 December 2009 Springer Science+Business Media, LLC 2009The Swiss Society for Biomaterials (SSB) has hosted the22nd European Conference on Biomaterials—ESB 2009from September 7 to September 11, 2009, in the BeaulieuConvention Center Lausanne. The ESB conferences are theannual conferences of the European Society for Biomate-rials (ESB) taking place the three years between two WorldBiomaterials Congresses.1044 regular abstracts ?23 last minute abstracts weresubmitted for presentation at ESB 2009 exceeding by farthe submissions to previous European Biomaterials Con-ferences. After rigorous reviewing and invitation, theconference program finally was composed of 10 plenarylectures, 4 award lectures (Jean Leray and George Winter,both for 2008 and 2009), 26 keynote lectures, of these halfinvited and half selected following the recommendations ofthe abstract reviewers, 156 regular talks, and 630 posters.Figure 1 shows the thematic allocation of all submittedabstracts, oral and posters, to the master keywords of theconference. From this figure becomes obvious that thetrends and topics analyzed after the World BiomaterialsCongress 2008 principally continued for the ESB 2009 [1].ESB 2009 had a very impressive scientific program withworld-renowned plenary speakers and presenters. Posterswere seen as an indispensable part of the ESB 2009.Therefore, all posters were visible on all four days of theESB 2009. The poster sessions, all breaks and specialevents provided excellent opportunities for in-depth dis-cussions, to gain new international contacts for futurecollaborations, and to exchange ideas.1201 attendees from 44 countries coming from allcontinents participated in the ESB 2009, a number slightlyhigher than at ESB 2005 in Sorrento, Italy. Figure 2 pro-vides some details of the attendance. The graph identifiesSwitzerland, UK, Germany, Spain, Italy, and France as thecountries with the highest number of participants. How-ever, also the attendance from the oversea countries Japan,USA, Brazil, and Australia was good.ESB 2009’s concept of dedicating one of the five par-allel session lines throughout the day to a ‘‘Theme of theDay’’ found wide acceptance. Each conference day startedwith an ESB award lecture followed by a plenary lecture onclinical problems within a ‘‘Theme of the Day’’ as well as aplenary lecture of the state of the art in research of thatarea. Particular highlights of the ESB 2009 were the ple-nary lectures of the opening and closing ceremonies pre-sented by Prof. Jeffrey A. Hubbell, Switzerland, and Prof.Buddy D. Ratner, USA. Pre-meeting and during meetingworkshops, which were mainly educational completed thescientific program.In addition to the ‘‘Theme of the Day’’, ESB 2009 hasinitiated accreditation by the European AccreditationCouncil for Continuing Medical Education (EACCME) toprovide CME credits. The Schweizerische Gesellschaft fu¨rOrthopa¨dische Chirurgie (SCO) allocated 25 points. TheEuropean Orthopedic Research Society (EORS) wasbrought as a new sister society to the ESB while the con-nections to current ESB sister societies were re-strength-ened by incorporation of special sessions into the program.ESB 2009 further strengthened the scientific basis ofthe traditional ESB core topics while encouraging theC. Wandrey (&)Ecole Polytechnique Fe´de´rale de Lausanne,Lausanne, Switzerlande-mail: christine.wandrey@epfl.chM. BohnerRMS Foundation, Bettlach, SwitzerlandG. RichardsAO Research Institute, Davos, Switzerland123J Mater Sci: Mater Med (2010) 21:843–845DOI 10.1007/s10856-009-3962-3interaction with both the clinical and industrial side ofbiomaterials. ESB 2009 has drawn on the extensive Med-Tech industry within Switzerland to bring closer workingrelationships with industry. More than 20 companies werepresent with an exhibition booth and a special exhibitorevening took place at the ‘‘Industrial Day’’.ESB 2009 has also introduced conflict of interest state-ments (Compulsory Presentation Statements) to let ESB2009 participants better interpret posters and talks declaringany potential conflict of interest that presenters might havewith the presented data. This will need more enforcementfor future meetings, as this was a partial success.0 10 20 30 40 50 60 70 80Biological response: cell/protein-materialBiomaterial surfacesTissue Engineering/regenerative medicineMaterial properties/characterizationCeramicsNanotechnology/nanostructured biomaterialsDrug/gene delivery (controlled release)ScaffoldsComposite biomaterialsBiological response: tissue-material interactionsInjectable biomaterialsMetalsSynthetic polymersMusculoskeletal tissues (bone, cartilage, muscle)BiomechanicsCardiovascular tissueModelingNervous tissuesBioactive agents (growth factors, enzymes, etc.)ImagingNatural polymersBioreactors (culture, loading)Self-assemblyArtificial organsBiosensors/electrodesSoft/skin tissueTranslational and clinical researchnumber of submitted abstractsFig. 1 Thematic abstract submission (master keywords) before evaluation. Black abstracts submitted to be considered as oral contribution, greyabstracts submitted for posters050100150200250300Switzerland UKGermanySpainItalyFranceJapanNetherlandsUSAIrelandSwedenKoreaPortugalRomaniaBrazilPolandAustraliaBelgiumCzech RepublicIndiaAustriaFinlandChinaGreeceIranDenmarkSingaporeTaiwanNorwayMalaysiaTurkeyCanadaRussiaHong KongIsraelSlovakiaBangladeshColumbiaEstoniaIraqMexicoMoldowiaThailandparticipantsFig. 2 Attendance at ESB 2009844 J Mater Sci: Mater Med (2010) 21:843–845123ESB 2009 succeeded to connect biomaterial researchwith current clinical problems to produce progressivetranslational research and was the venue to present anddiscuss basic, applied/translational and clinical research ina multi-disciplinary environment. This special issue ofJMSMM is a collection of invited contributions proposedby reviewers during the reviewing and selection process.The organizers again thank all institutions, organiza-tions, and companies that have supported ESB 2009 andalso recognize the efforts of all committee members andreviewers who have helped to organize the scientificprogram, workshops, forums, exhibition and special events.However, finally, the activities of the participants made theESB 2009 a very successful and rewarding meeting.Reference1. Leeuwenburgh SCG, et al. Trends in biomaterials research: ananalysis of the scientific programme of the World BiomaterialsCongress 2008. Biomaterials. 2008;29:3047–52.J Mater Sci: Mater Med (2010) 21:843–845 845123

The 22nd European Conference on Biomaterials: retrospective view, facts and figures

http://doc.rero.ch/record/318558/files/10856_2009_Article_3962.pdf

The 22nd European Conference on Biomaterials: retrospective view, facts and figures

Abstract

Similar works

Full text

Available Versions

RERO DOC Digital Library